Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C

Figure 4

Comparison of PTX3 with other indicators, such as hyaluronic acid (HA), transforming growth factor‐ (TGF-), the aspartate aminotransferase (AST) to platelet ratio index (APRI index), the FIB‐4 score, gamma-glutamyltranspeptidase to platelet ratio (GPR ratio), and liver stiffness measurement (LSM), for the diagnosis of significant fibrosis (F≥2) by areas under the receiver operating curves (ROC).